Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › miRNA-212/132 family as a therapeutic target

miRNA-212/132 family as a therapeutic target

US Patent 9388411 · Granted Jul 12, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid compounds for binding to complement component 3 protein2022
IncRNAS for therapy and diagnosis of angiogenesis2022
LncRNAs for therapy and diagnosis of cardiac hypertrophy2022
Compound for treatment of heart failure2021
Natural compounds and fibrosis2021
LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling2021
LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling2021
Mitochondrial non-coding RNAs for predicting disease progression in heart failur2020
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes2019
LncRNAs for therapy and diagnosis of angiogenesis2019
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes2018
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes2017